{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T02:46:41Z","timestamp":1794192401067,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH Intramural Program, Center for Cancer Research, National Cancer Institute and the NIH AIDS Intramural Targeted Program (IATAP)."},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206175\/Z\/17\/Z"],"award-info":[{"award-number":["206175\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107005\/Z\/15Z"],"award-info":[{"award-number":["107005\/Z\/15Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC001061"],"award-info":[{"award-number":["FC001061"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health Research (NIHR) Imperial Biomedical Research Centre (BRC)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Between 10 and 20 million people worldwide are infected with the human T-cell lymphotropic virus type 1 (HTLV-1). Despite causing life-threatening pathologies there is no therapeutic regimen for this deltaretrovirus. Here, we screened a library of integrase strand transfer inhibitor (INSTI) candidates built around several chemical scaffolds to determine their effectiveness in limiting HTLV-1 infection. Naphthyridines with substituents in position 6 emerged as the most potent compounds against HTLV-1, with XZ450 having highest efficacy in vitro. Using single-particle cryo-electron microscopy we visualised XZ450 as well as the clinical HIV-1 INSTIs raltegravir and bictegravir bound to the active site of the deltaretroviral intasome. The structures reveal subtle differences in the coordination environment of the Mg<jats:sup>2+<\/jats:sup> ion pair involved in the interaction with the INSTIs. Our results elucidate the binding of INSTIs to the HTLV-1 intasome and support their use for pre-exposure prophylaxis and possibly future treatment of HTLV-1 infection.<\/jats:p>","DOI":"10.1038\/s41467-021-25284-1","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T10:05:02Z","timestamp":1629194702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Structural basis for the inhibition of HTLV-1 integration inferred from cryo-EM deltaretroviral intasome structures"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-6915","authenticated-orcid":false,"given":"Michal S.","family":"Barski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-4138","authenticated-orcid":false,"given":"Teresa","family":"Vanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1006-6364","authenticated-orcid":false,"given":"Xue Zhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9207-1671","authenticated-orcid":false,"given":"Steven J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4735-4984","authenticated-orcid":false,"given":"Allison","family":"Ballandras-Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora B.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-2992","authenticated-orcid":false,"given":"Valerie E.","family":"Pye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9176-4377","authenticated-orcid":false,"given":"Stephen H.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9925-8586","authenticated-orcid":false,"suffix":"Jr.","given":"Terrence R.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-538X","authenticated-orcid":false,"given":"Peter","family":"Cherepanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1963-8026","authenticated-orcid":false,"given":"Goedele N.","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"25284_CR1","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3389\/fmicb.2017.01425","volume":"8","author":"Y Tagaya","year":"2017","unstructured":"Tagaya, Y. & Gallo, R. C. The exceptional oncogenicity of HTLV-1. Front. Microbiol. 8, 1425 (2017).","journal-title":"Front. Microbiol."},{"key":"25284_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11899-007-0035-x","volume":"2","author":"R Mahieux","year":"2007","unstructured":"Mahieux, R. & Gessain, A. Adult T-cell leukemia\/lymphoma and HTLV-1. Curr. Hematol. Malig. Rep. 2, 257\u2013264 (2007).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"25284_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jns.2016.10.030","volume":"371","author":"E Matsuura","year":"2016","unstructured":"Matsuura, E. et al. HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): a comparative study to identify factors that influence disease progression. J. Neurol. Sci. 371, 112\u2013116 (2016).","journal-title":"J. Neurol. Sci."},{"key":"25284_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain, A. & Cassar, O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 3, 388 (2012).","journal-title":"Front. Microbiol."},{"key":"25284_CR5","doi-asserted-by":"publisher","first-page":"e0008761","DOI":"10.1371\/journal.pntd.0008761","volume":"14","author":"C Rosadas","year":"2020","unstructured":"Rosadas, C. et al. Health state utility values in people living with HTLV-1 and in patients with HAM\/TSP: the impact of a neglected disease on the quality of life. PLoS Negl. Trop. Dis. 14, e0008761 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"25284_CR6","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1093\/jpids\/piu070","volume":"3","author":"AB Carneiro-Proietti","year":"2014","unstructured":"Carneiro-Proietti, A. B. et al. Mother-to-child transmission of human t-cell lymphotropic viruses-1\/2: what we know, and what are the gaps in understanding and preventing this route of infection. J. Pediatr. Infect. Dis. Soc. 3, S24\u201329 (2014).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"25284_CR7","doi-asserted-by":"publisher","first-page":"e1007470","DOI":"10.1371\/journal.pcbi.1007470","volume":"16","author":"DJ Laydon","year":"2020","unstructured":"Laydon, D. J., Sunkara, V., Boelen, L., Bangham, C. R. M. & Asquith, B. The relative contributions of infectious and mitotic spread to HTLV-1 persistence. PLoS Comput. Biol. 16, e1007470 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"25284_CR8","doi-asserted-by":"crossref","unstructured":"Marino-Merlo, F. et al. Antiretroviral therapy in HTLV-1 infection: an updated overview. Pathogens 9, 342 (2020).","DOI":"10.3390\/pathogens9050342"},{"key":"25284_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3389\/fmicb.2019.01877","volume":"10","author":"MS Barski","year":"2019","unstructured":"Barski, M. S., Minnell, J. J. & Maertens, G. N. Inhibition of HTLV-1 infection by HIV-1 first- and second-generation integrase strand transfer inhibitors. Front. Microbiol. 10, 1877 (2019).","journal-title":"Front. Microbiol."},{"key":"25284_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1021\/acschembio.5b00948","volume":"11","author":"XZ Zhao","year":"2016","unstructured":"Zhao, X. Z. et al. HIV-1 integrase strand transfer inhibitors with reduced susceptibility to drug resistant mutant integrases. ACS Chem. Biol. 11, 1074\u20131081 (2016).","journal-title":"ACS Chem. Biol."},{"key":"25284_CR11","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1021\/acs.jmedchem.7b00596","volume":"60","author":"XZ Zhao","year":"2017","unstructured":"Zhao, X. Z. et al. Structure-guided optimization of hiv integrase strand transfer inhibitors. J. Med. Chem. 60, 7315\u20137332 (2017).","journal-title":"J. Med. Chem."},{"key":"25284_CR12","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1073\/pnas.200139397","volume":"97","author":"AS Espeseth","year":"2000","unstructured":"Espeseth, A. S. et al. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc. Natl. Acad. Sci. USA 97, 11244\u201311249 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"25284_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature08784","volume":"464","author":"S Hare","year":"2010","unstructured":"Hare, S., Gupta, S. S., Valkov, E., Engelman, A. & Cherepanov, P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464, 232\u2013236 (2010).","journal-title":"Nature"},{"key":"25284_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.aay8015","volume":"367","author":"DO Passos","year":"2020","unstructured":"Passos, D. O. et al. Structural basis for strand-transfer inhibitor binding to HIV intasomes. Science 367, 810\u2013814 (2020).","journal-title":"Science"},{"key":"25284_CR15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.aay4919","volume":"367","author":"NJ Cook","year":"2020","unstructured":"Cook, N. J. et al. Structural basis of second-generation HIV integrase inhibitor action and viral resistance. Science 367, 806\u2013810 (2020).","journal-title":"Science"},{"key":"25284_CR16","doi-asserted-by":"crossref","unstructured":"Barski, M. S. et al. Cryo-EM structure of the deltaretroviral intasome in complex with the PP2A regulatory subunit B56gamma. Nat. Commun. 11, 5043 (2020).","DOI":"10.1038\/s41467-020-18874-y"},{"key":"25284_CR17","doi-asserted-by":"publisher","first-page":"e02203-02217\/02","DOI":"10.1128\/JVI.02203-17","volume":"92","author":"PL Boyer","year":"2018","unstructured":"Boyer, P. L. et al. Developing and evaluating inhibitors against the RNase H active site of HIV-1 reverse transcriptase. J. Virol. 92, e02203-02217\/02201-e02203\u201302217\/02226 (2018).","journal-title":"J. Virol."},{"key":"25284_CR18","doi-asserted-by":"publisher","first-page":"e01318","DOI":"10.1128\/mBio.01318-14","volume":"5","author":"Z Yan","year":"2014","unstructured":"Yan, Z. et al. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses. mBio 5, e01318\u201301314 (2014).","journal-title":"mBio"},{"key":"25284_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16963-6","volume":"11","author":"V Bhatt","year":"2020","unstructured":"Bhatt, V. et al. Structural basis of host protein hijacking in human T-cell leukemia virus integration. Nat. Commun. 11, 3121 (2020).","journal-title":"Nat. Commun."},{"key":"25284_CR20","doi-asserted-by":"publisher","first-page":"O12","DOI":"10.1186\/1742-4690-11-S1-O12","volume":"11","author":"M Miura","year":"2014","unstructured":"Miura, M. et al. STLV-1-infected Japanese macaque as a model of HTLV-1 infection. Retrovirology 11, O12\u2013O12 (2014).","journal-title":"Retrovirology"},{"key":"25284_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.molcel.2016.06.024","volume":"63","author":"EPT Hertz","year":"2016","unstructured":"Hertz, E. P. T. et al. A conserved motif provides binding specificity to the PP2A-B56 phosphatase. Mol. Cell 63, 686\u2013695 (2016).","journal-title":"Mol. Cell"},{"key":"25284_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.molcel.2017.11.034","volume":"69","author":"T Kruse","year":"2018","unstructured":"Kruse, T. et al. The ebola virus nucleoprotein recruits the host PP2A-B56 phosphatase to activate transcriptional support activity of VP30. Mol. Cell 69, 136\u2013145 e136 (2018).","journal-title":"Mol. Cell"},{"key":"25284_CR23","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.1128\/AAC.01474-16","volume":"60","author":"M Tsiang","year":"2016","unstructured":"Tsiang, M. et al. Antiviral activity of bictegravir (GS-9883), a novel potent HIV-1 integrase strand transfer inhibitor with an improved resistance profile. Antimicrob. Agents Chemother. 60, 7086\u20137097 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"25284_CR24","first-page":"1333","volume":"11","author":"NM King","year":"2004","unstructured":"King, N. M., Prabu-Jeyabalan, M., Nalivaika, E. A. & Schiffer, C. A. Combating susceptibility to drug resistance: lessons from HIV-1 protease. Chem. Biol. 11, 1333\u20131338 (2004).","journal-title":"Chem. Biol."},{"key":"25284_CR25","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/AAC.01413-10","volume":"55","author":"ME Seegulam","year":"2011","unstructured":"Seegulam, M. E. & Ratner, L. Integrase inhibitors effective against human T-cell leukemia virus type 1. Antimicrob. Agents Chemother. 55, 2011\u20132017 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"25284_CR26","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.1010246107","volume":"107","author":"S Hare","year":"2010","unstructured":"Hare, S. et al. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc. Natl. Acad. Sci. USA 107, 20057\u201320062 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"25284_CR27","doi-asserted-by":"publisher","first-page":"15910","DOI":"10.1073\/pnas.1002346107","volume":"107","author":"L Krishnan","year":"2010","unstructured":"Krishnan, L. et al. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc. Natl. Acad. Sci. USA 107, 15910\u201315915 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"25284_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1021\/cb300471n","volume":"8","author":"M Metifiot","year":"2013","unstructured":"Metifiot, M. et al. Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem. Biol. 8, 209\u2013217 (2013).","journal-title":"ACS Chem. Biol."},{"key":"25284_CR29","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1021\/acs.jmedchem.5b01037","volume":"58","author":"IT Raheem","year":"2015","unstructured":"Raheem, I. T. et al. Discovery of 2-pyridinone aminals: a prodrug strategy to advance a second generation of HIV-1 integrase strand transfer inhibitors. J. Med. Chem. 58, 8154\u20138165 (2015).","journal-title":"J. Med. Chem."},{"key":"25284_CR30","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.bmcl.2017.02.039","volume":"27","author":"JD Schreier","year":"2017","unstructured":"Schreier, J. D. et al. Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV. Bioorg. Med. Chem. Lett. 27, 2038\u20132046 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"25284_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0168-1702(01)00287-8","volume":"78","author":"A Machuca","year":"2001","unstructured":"Machuca, A., Rodes, B. & Soriano, V. The effect of antiretroviral therapy on HTLV infection. Virus Res. 78, 93\u2013100 (2001).","journal-title":"Virus Res."},{"key":"25284_CR32","doi-asserted-by":"crossref","unstructured":"Chouchana, L., Beeker, N. & Treluyer, J. M. Is there a safety signal for dolutegravir and integrase inhibitors during pregnancy? J. Acquir. Immune Defic. Syndr. 81, 481\u2013486 (2019).","DOI":"10.1097\/QAI.0000000000002065"},{"key":"25284_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/QAI.0000000000001924","volume":"80","author":"V Rasi","year":"2019","unstructured":"Rasi, V., Cortina-Borja, M., Peters, H., Sconza, R. & Thorne, C. Brief report: surveillance of congenital anomalies after exposure to raltegravir or elvitegravir during pregnancy in the United Kingdom and Ireland, 2008-2018. J. Acquir. Immune Defic. Syndr. 80, 264\u2013268 (2019).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"25284_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40262-018-0684-z","volume":"58","author":"R van der Galien","year":"2019","unstructured":"van der Galien, R. et al. Pharmacokinetics of HIV-integrase inhibitors during pregnancy: mechanisms, clinical implications and knowledge gaps. Clin. Pharmacokinet. 58, 309\u2013323 (2019).","journal-title":"Clin. Pharmacokinet."},{"key":"25284_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40262-020-00898-8","volume":"59","author":"AT Podany","year":"2020","unstructured":"Podany, A. T., Scarsi, K. K., Pham, M. M. & Fletcher, C. V. Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors: an updated review. Clin. Pharmacokinet. 59, 1085\u20131107 (2020).","journal-title":"Clin. Pharmacokinet."},{"key":"25284_CR36","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1001\/jama.1987.03390190082024","volume":"257","author":"C Bartholomew","year":"1987","unstructured":"Bartholomew, C. et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 257, 2604\u20132608 (1987).","journal-title":"JAMA"},{"key":"25284_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bjid.2018.11.003","volume":"22","author":"LS Castro","year":"2018","unstructured":"Castro, L. S. et al. Human T cell lymphotropic virus type 1 infection among men who have sex with men in Central Brazil. Braz. J. Infect. Dis. 22, 472\u2013476 (2018).","journal-title":"Braz. J. Infect. Dis."},{"key":"25284_CR38","doi-asserted-by":"publisher","first-page":"e0171303","DOI":"10.1371\/journal.pone.0171303","volume":"12","author":"D Nunes","year":"2017","unstructured":"Nunes, D. et al. HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil. PLoS ONE 12, e0171303 (2017).","journal-title":"PLoS ONE"},{"key":"25284_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/nar\/gkv1347","volume":"44","author":"GN Maertens","year":"2016","unstructured":"Maertens, G. N. B\u2019-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase. Nucleic Acids Res. 44, 364\u2013376 (2016).","journal-title":"Nucleic Acids Res."},{"key":"25284_CR40","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1021\/bi801372d","volume":"47","author":"DR Langley","year":"2008","unstructured":"Langley, D. R. et al. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors. Biochemistry 47, 13481\u201313488 (2008).","journal-title":"Biochemistry"},{"key":"25284_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jsb.2015.11.006","volume":"193","author":"CJ Russo","year":"2016","unstructured":"Russo, C. J. & Passmore, L. A. Ultrastable gold substrates: properties of a support for high-resolution electron cryomicroscopy of biological specimens. J. Struct. Biol. 193, 33\u201344 (2016).","journal-title":"J. Struct. Biol."},{"key":"25284_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14898-6","volume":"11","author":"C Lancey","year":"2020","unstructured":"Lancey, C. et al. Structure of the processive human Pol delta holoenzyme. Nat. Commun. 11, 1109 (2020).","journal-title":"Nat. Commun."},{"key":"25284_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"25284_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"25284_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jmb.2003.07.013","volume":"333","author":"PB Rosenthal","year":"2003","unstructured":"Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721\u2013745 (2003).","journal-title":"J. Mol. Biol."},{"key":"25284_CR46","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nmeth.2115","volume":"9","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. & Chen, S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853\u2013854 (2012).","journal-title":"Nat. Methods"},{"key":"25284_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/pro.3293","volume":"27","author":"JB Heymann","year":"2018","unstructured":"Heymann, J. B. Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs. Protein Sci. 27, 159\u2013171 (2018).","journal-title":"Protein Sci."},{"key":"25284_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1878-3","volume":"18","author":"X Min","year":"2017","unstructured":"Min, X. et al. Predicting enhancers with deep convolutional neural networks. BMC Bioinformatics 18, 478 (2017).","journal-title":"BMC Bioinformatics"},{"key":"25284_CR49","doi-asserted-by":"publisher","unstructured":"Terwilliger, T. C., Ludtke, S. J., Read, R. J., Adams, P. D. & Afonine, P. V. Improvement of cryo-EM maps by density modification. bioRxiv, 845032, https:\/\/doi.org\/10.1101\/845032 (2020).","DOI":"10.1101\/845032"},{"key":"25284_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"25284_CR51","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D. Biol. Crystallogr 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"25284_CR52","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"25284_CR53","doi-asserted-by":"publisher","first-page":"e1006030","DOI":"10.1371\/journal.ppat.1006030","volume":"12","author":"AG Rowan","year":"2016","unstructured":"Rowan, A. G. et al. T cell receptor Vbeta staining identifies the malignant clone in adult T cell leukemia and reveals killing of leukemia cells by autologous CD8+ T cells. PLoS Pathog. 12, e1006030 (2016).","journal-title":"PLoS Pathog."},{"key":"25284_CR54","doi-asserted-by":"publisher","first-page":"e1005560","DOI":"10.1371\/journal.ppat.1005560","volume":"12","author":"K Manivannan","year":"2016","unstructured":"Manivannan, K., Rowan, A. G., Tanaka, Y., Taylor, G. P. & Bangham, C. R. CADM1\/TSLC1 identifies HTLV-1-infected cells and determines their susceptibility to CTL-mediated lysis. PLoS Pathog. 12, e1005560 (2016).","journal-title":"PLoS Pathog."},{"key":"25284_CR55","doi-asserted-by":"publisher","first-page":"10580","DOI":"10.1128\/JVI.01799-15","volume":"89","author":"S Alais","year":"2015","unstructured":"Alais, S., Mahieux, R. & Dutartre, H. Viral source-independent high susceptibility of dendritic cells to human T-cell leukemia virus type 1 infection compared to that of T lymphocytes. J. Virol. 89, 10580\u201310590 (2015).","journal-title":"J. Virol."},{"key":"25284_CR56","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1016\/j.bmcl.2011.03.047","volume":"21","author":"XZ Zhao","year":"2011","unstructured":"Zhao, X. Z. et al. Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Bioorg. Med. Chem. Lett. 21, 2986\u20132990 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"25284_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1747-0285.2011.01270.x","volume":"79","author":"XZ Zhao","year":"2012","unstructured":"Zhao, X. Z. et al. Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Chem. Biol. Drug Des. 79, 157\u2013165 (2012).","journal-title":"Chem. Biol. Drug Des."}],"updated-by":[{"DOI":"10.1038\/s41467-021-26243-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25284-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T17:06:42Z","timestamp":1675616802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25284-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25284"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25284-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-021-26243-6","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-021-26243-6","URL":"https:\/\/doi.org\/10.1038\/s41467-021-26243-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4996"}}